The molecular energetics of the failing heart from animal models - Large animal models

Heart Failure Reviews

Volumn 4, Issue 3, 1999, Pages 255-267

  Zhang, Jianyi ^a,b   Bache, Robert J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

31P NMR spectroscopy; Creatine kinase; Heart failure; High energy phosphates; Hypertrophy; Ischemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CREATINE; CREATINE KINASE; CREATINE PHOSPHATE; GLUCOSE;

BIOENERGY; ENERGY METABOLISM; EXPERIMENTAL MODEL; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE INFARCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART VENTRICLE REMODELING; HIGH ENERGY PHOSPHATE; MITOCHONDRIAL ENERGY TRANSFER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE PHOSPHORYLATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; REVIEW; TACHYCARDIA; TISSUE OXYGENATION;

EID: 0033502073     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009814124314     Document Type: Review

References (65)

1. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810-1818.
2. From AHL, Zimmer SD, Michurski SP, Mohanakrishnan P, Ulstad VK, Thoma WJ, Ugurbil K. Regulation of the oxidative phosphorylation rate in the intact cell. Biochemistry 1990;29:3731-3743.
3. Bottomley PA. MR spectroscopy of the human heart: The status and the challenges. Radiology 1994;191:593-612.
4. 31P magnetic resonance spectroscopy of the Sherpa heart: A phosphocreatine/adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc Nat Acad Sci 1996;93:1215-1220.
5. Neubauer S, Horn M, Godde M, Ertl G, Ingwall JS. The myocardial phosphocreatine/ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190-2196.
6. Balaban RS, Kantor HL, Katz LA, Briggs RW Relation between work and phosphate metabolites in the in vivo paced mammalian heart. Science 1986;232:1121-1123.
7. Path G, Robitaille P-M, Merkle H, Tristani M, Zhang J, Garwood M, From AHL, Bache RJ, Ugurbil K. The correlation between transmural high energy phosphate levels and myocardial blood flow in the presence of graded coronary stenosis. Circ Res 1990;67:660-673.
8. Schaefer S, Schwartz GG, Wisneski JA Trocha SD, Christoph I, Steinman SK, Garcia J, Massie BM, Weiner MW. Response of high-energy phosphates and lactate release during prolonged regional ischemia in vivo. Circulation 1992;85:342-349.
9. Murakami Y, Zhang Y, Cho YK, Mansoor AM, Chung JK, Chu C, Francis G, Ugurbil K, Bache RJ, From AHL, Jerosch-Herold M, Wilke N, Zhang J. Myocardial oxygenation during high work states in hearts with postinfarction remodeling. Circulation 1999;99:942-948.
10. Zhang J, Merkle H, From AHL, Ugurbil K, Bache RJ. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 1993;92:993-1003.
11. Massie BM, Schwartz GG, Garcia J, Wisneski JA, Weiner MW, Twyman O. Myocardial metabolism during increased work states in the porcine left ventricle in vivo. Circ Res 1994;74:64-73.
12. Bache RJ, Zhang J, Path G, From AHL, Bache RJ, Ugurbil K. Myocardial high energy phosphate levels during tachycardia and inotropic stimulation in the chronically pressure overloaded hypertrophied left ventricle. Am J Physiol 1994;266:H1959-1970.
13. Massie BM, Schaefer S, Garcia J, McKirnan D, Schwartz GG, Wisneski JA, Weiner MW, White FC. Myocardial highenergy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation 1995;91:1814-1823.
14. Zhang J, Path G, Chepuri V, Homans DC, Merkle H, Hendrich, K, Ugurbil K, Bache RJ, From AHL. Effects of dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to a coronary stenosis. Implications with regard to dobutamine stress testing. Am Heart J 1995;129:330-342.
15. Zhang J, McDonald K. Bioenergetic consequence of left ventricular remodeling secondary to discrete myocardial infarction. Circulation 1995;92:1011-1019.
16. 31P NMR study. Am J Physiol 1995;268:H1891-H1905.
17. 31P NMR spectroscopic study. Circulation 1995;92:1274-1283.
18. 31P MRS study. Circulation 1996;94: 1089-1099.
19. Zhang J, Toher C, Erhard M, Zhang Y, Ugurbil K, Bache RJ, Lange T, Homans DC. Bioenergetic and functional consequences of left ventricular volume overload hypertrophy. Circulation 1997;96:334-343.
20. Ingwall JS. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Amer J Physiol 1982;242:H729-H744.
21. 1H NMR spectroscopy study. Magn Reson Med 1997;38:193-197.
22. Gong G, Ugurbil K, Zhang J. Transmural metabolic heterogeneity at high cardiac work states. Am J Physiol/Heart Circ Physiol 1999;277(46):H236-H242.
23. Pantely G A, Malone SA, Rhen WS, Anselone CG, Arai A, Bristow JD. Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res 1990;67:1481-1493.
24. Neubauer S, Horn M, Naumann A, Tian R, Hu K, Laser M, Friedrich J, Gaudron P, Schnackerz K, Ingwall JS, Ertl G. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest 1995;95:1092-1100.
25. Zimmer GA, Zimmermann R, Hess OMS, Schneider J, Kubler W, Krayenbuehl HP, Hagl S, Mall, G. Decreased concentration of myofibrils and myofiber hypertrophy are structural determinants of impaired left ventricular function in patients with chronic heart diseases: A multiple logistic regression analysis. JACC 1992;20:1135-1142.
26. Schwartz A, Sordahl LA, Entman ML, Allen JC, Reddy YS, Goldstein MA, Luchi RJ, Wyborny LE. Abnormal biochemistry in myocardial failure. Am J Cardiol 1975;32:407-422.
27. Alpert NR, Muleiri LA, Hasenfuss G, Holubarsch. Myocyte reorganization in hypertrophied and failing hearts. Eur Heart J 1995;16:2-7.
28. Harding SE, Jones M, Vescovo G, Del Monte F, Poole-Wilson PA. Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol 1992;223:39-48.
29. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H, Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 1995;92:1169-1178.
30. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Holubarsch C, Just H, Alpert NR. Contractile protein function in failing and nonfailing human myocardium. Basic Res Cardiol 1992; 87:106.
31. Hasenfuss G, Mulieri LA, Leavitt BJ, Alien PD, Haeberle JR, Alpert NR. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res 1992;70:1225-1232.
32. Anversa P, Beghi C, Kikkawa Y, Olivetti G. Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. Am J Path 1985;118:484-492.
33. Alyono D, Anderson RW, Parrish DG, Dai X, Bache RJ. Alterations of myocardial blood flow associated with experimental canine left ventricular hypertrophy secondary to valvular aortic stenosis. Circ Res 1986;58:47-57.
34. Bishop SP, Meisen LR. Myocardial necrosis, fibrosis, and DNA synthesis in experimental cardiac hypertrophy induced by sudden pressure overload. Circ Res 1976;39: 238-245.
35. Henry TD, Zhang J, Cepuri V, Fashingbauer P, Gormick CC, Ugurbil K, Bache RJ, From AHL. Effects of dobutamine on myocardial bioenergetics in pacing induced heart failure. Circulation 1991;84(Suppl II):II-380.
36. Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 1994;26:1371-1375.
37. El Alaqui-Talibi Z, Landormy S, Loireau A, Moravec J. Fatty acid oxidation and mechanical performance of volumeoverloaded rat hearts. Am J Physiol 1992;262:H1068-1074.
38. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 1989;322:100-110.
39. El Alaoui-Talibi Z, Moravec J. Carnitine transport and exogenous palmitate oxidation in chronically volume-ooverloaded hearts. Biochim Biophys Acta 1989;1003:109-114.
40. Regitz V, Bossaller C, Strasser R, Muller M, Shug AL, Fleck E. Metabolic alterations in end stage and less severe heart failure-myocardial carnitine decrease. J Clin Chem Clin Biochem 1990;28:611-617.
41. Pierpont MEM, Foker JE, Pierpont GL. Myocardial carnitine metabolism in congestive heart failure induced by incessant tachycardia. Basic Res Cardiol 1993;88:362-370.
42. Iliceto S, Scrutino D, Bruzzi P, et al. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: The L-carnitine echocardiografia digitalizzata infarto myocardico (CEDIM) trial. J Am Coll Cardiol 1995;36:380-387.
43. Arai A, Kasserra C, Hopkins J, Gandjbakhche, Bonner R, Balaban R. Optical reflectance spectroscopy measures cellular oxygenation in vivo: Effects of work Circulation 1997;96:I-692 (Abstract).
44. Van Gitters RL, Franklin DL. Cardiovascular performance of Alaska sled dogs during exercise. Circ Res 1969;24:33-42.
45. Leier CV, Binkley PF. Parenteral inotropic support for advanced congestive heart failure. Prog Cardiovasc Dis 1998;41:207-224.
46. 2 in heart and skeletal muscle. Physiologist 1971;14:69-82.
47. Antonini E, Brunori M. Hemoglobin and Myoglobin in Their Reactions with Ligands. Amsterdam: North-Holland Publ Co., 1971:220.
48. Schenkman K, Marble D, Burns D, Feigl E. Myoglobin oxygen dissociation by multiwavelength spectroscopy. J Appl Physiol 1997;82:86-92.
49. 2 in individual cardiomyocytes in dogs, cats, rabbits, ferrets and rats. Am J Physiol 1991;260:H522-H531.
50. Parsons WJ, Rembert JC, Bauman RP, Greenfield JC, Plantadosi CA. Dynamic mechanisms of cardiac oxygenation during brief ischemia and reperfusion. Am J Physiol 1990;259:H1477-H1485.
51. Tamura M, Hazeki O, Nioka S, Chance B. In vivo study of tissue oxygen metabolism using optical and nuclear magnetic resonance spectroscopy. Annu Rev Physiol 1989;51: 813-834.
52. 1H-nuclear magnetic resonance deoxymyoglobin signal as indicator of intracellular oxygenation in myocardium. Am J Physiol 1991;261:H2091-H2097.
53. 1H nuclear magnetic resonance signal of myoglobin. Am J Physiol 1995;268:H1675-H1681.
54. 1H NMR signal of the myoglobin Val-E11 in myocardium: An index of cellular oxygenation. Proc Natl Acad Sci 1992;89:4731-4733.
55. Zhang J, Murakami Y, Zhang Y, Cho YK, Ye Y, Gong G, Bache RJ, Ugurbil K, From AHL. Oxygen delivery does not limit cardiac performance during high work states. Am J Physiol Heart Circ Physiol 1999;276/(45):H50-H57.
56. Wyss M, Smeitink J, Wevers RA, Wallimann T. Mitochondrial creatine kinase: A key enzyme of aerobic energy metabolism. Biochem Biophysica Acta 1992;1102:119-166.
57. Sata M, Sugiura S, Yamashita H, Momomura S-I, Serizawa T. Coupling between myosin ATPase cycle and creatine kinase cycle facilitates cardiac actomyosin sliding in vitro. Circulation 1996;93:310-317.
58. Bessman SP, Carpenter CL. The creatine-creatine phosphate energy shuttle. Ann Rev Biochim 1985;54:831-862.
59. Ingwall, JS. Is cardiac failure a consequence of decreased energy reserve? Circulation 1993;87(Suppl VII):VII-58-VII-62.
60. Chuong DH, Zhang J, Payne RM, Apple F. Post-infarction left ventricular remodeling induces changes in creatine kinase mRNA and protein subunit levels in porcine myocardium. Am J Pathol 1997;151:257-264.
61. Murakami Y, Zhang J, Eijgelshoven MHJ, Cho YK, Bache RJ. Myocardial creatine kinase kinetics in hearts with severe LV remodeling. Am J Physiology 1999;276:H892-H900.
62. Portman MA, Ning XH. Maturational changes in respiratory control through creatine kinase in heart in vivo. Am J Physiol 1992;263:C453-C460.
63. Tian R, Ingwall JS. Energetic basis for reduced contractile reserve in isolated rat hearts. Am J Physiol/Heart Circ Physiol 1996;270(39):H1207-H1216.
64. Kapelko VI, Kupriyanov VV, Novikova NA, Lakomkin VL, Steinschneider AY, Severina MY, Veksler VI, Saks VA. The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency. J Mol Cell Cardiol 1988;20:465-479.
65. Saupe KW, Spindler M, Tian R, Ingwall JS. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Cir Res 1998;82:898-907.